S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Teva Pharmaceutical Industries Earnings Date, Estimates & Call Transcripts (2022)

+0.37 (+4.92%)
(As of 07/1/2022 04:50 PM ET)
Today's Range
50-Day Range
52-Week Range
559,854 shs
Average Volume
11.48 million shs
Market Capitalization
$8.71 billion
P/E Ratio
Dividend Yield
Price Target

Earnings Summary

Earnings Date
Jul. 27Confirmed
Actual EPS
(May. 3)
Consensus EPS
(May. 3)
Last Year's Q2 EPS
Skip Charts & View Estimated and Actual Earnings Data

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teva Pharmaceutical Industries Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20222$0.61$0.61$0.61 
Q2 20223$0.56$0.66$0.60 
Q3 20223$0.62$0.64$0.63 
Q4 20223$0.64$0.75$0.69 
FY 202211$2.43$2.66 $2.53

TEVA Earnings Date and Information

Teva Pharmaceutical Industries last issued its earnings data on May 3rd, 2022. The reported $0.53 EPS for the quarter, meeting the consensus estimate of $0.53. The firm earned $3.66 billion during the quarter, compared to analyst estimates of $3.75 billion. Its revenue was down 8.1% on a year-over-year basis. Teva Pharmaceutical Industries has generated ($0.55) earnings per share over the last year (($0.55) diluted earnings per share). Earnings for Teva Pharmaceutical Industries are expected to grow by 4.18% in the coming year, from $2.39 to $2.49 per share. Teva Pharmaceutical Industries has confirmed that its next quarterly earnings report will be published on Wednesday, July 27th, 2022. Teva Pharmaceutical Industries will be holding an earnings conference call on Wednesday, July 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Teva Pharmaceutical Industries Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/3/2022Q1 2022$0.53$0.53$1.92$3.75 billion$3.66 billion    
2/9/2022Q4 2021$0.70$0.74+$0.04$1.62$4.28 billion$4.10 billion    
10/27/20219/30/2021$0.65$0.59($0.06)$0.88$4.05 billion$3.89 billion    
7/28/20216/30/2021$0.55$0.59+$0.04$0.95$4.03 billion$3.91 billion    
4/28/20213/31/2021$0.55$0.63+$0.08$1.13$4.04 billion$3.98 billion  
2/10/202112/31/2020$0.63$0.68+$0.05$1.14$4.37 billion$4.45 billion  
11/5/20209/30/2020$0.58$0.58$5.09$4.09 billion$4.00 billion  
8/5/20206/30/2020$0.53$0.55+$0.02$0.91$3.94 billion$3.87 billion  
5/7/20203/31/2020$0.59$0.76+$0.17$1.40$4.15 billion$4.36 billion  
2/12/202012/31/2019$0.61$0.62+$0.01$1.12$4.35 billion$4.47 billion  
11/7/2019Q3 2019$0.58$0.56($0.02)$1.41$4.25 billion$4.26 billion  
8/7/20196/30/2019$0.55$0.57+$0.02$1.77$4.25 billion$4.34 billion  
5/2/20193/31/2019$0.55$0.57+$0.02$1.24$4.38 billion$4.30 billion  
2/13/201912/31/2018$0.53$0.53$3.95$4.52 billion$4.56 billion
11/1/20189/30/2018$0.53$0.64+$0.11$1.55$4.54 billion$4.53 billion
8/2/20186/30/2018$0.64$0.78+$0.14$1.74$4.75 billion$4.70 billion
5/3/20183/31/2018$0.63$0.91+$0.28$0.79$4.80 billion$5.07 billion
2/8/2018Q4 17$0.77$0.91+$0.14$13.23$5.29 billion$5.46 billion  
11/2/2017Q3 2017$1.03$0.95($0.08)$1.38$5.61 billion$5.61 billion
8/3/20176/30/2017$1.06$0.99($0.07)$7.92$5.72 billion$5.69 billion  
5/11/2017Q1 17$1.06$1.06$1.49$5.69 billion$5.63 billion
2/13/2017Q4 2016$1.32$1.36+$0.04$3.82$6.26 billion$6.25 billion
11/15/2016Q3 2016$1.28$1.28$2.21$5.71 billion$5.56 billion
8/4/2016Q2 2016$1.18$1.25+$0.07$2.30$4.86 billion$5.00 billion
5/9/2016Q1 2016$1.13$1.18+$0.05$1.74$4.78 billion$4.81 billion
2/11/2016Q4 2015$1.28$1.28$2.01$4.83 billion$4.88 billion  
10/29/2015Q3 2015$1.29$1.35+$0.06$2.58$4.75 billion$4.80 billion  
7/30/2015Q2 2015$1.31$1.43+$0.12$2.23$4.90 billion$4.97 billion  
4/30/2015Q1 2015$1.26$1.36+$0.10$2.20$4.84 billion$5.00 billion
2/5/2015Q4 2014$1.30$1.31+$0.01$1.82$5.17 billion$5.17 billion
10/30/2014Q3 2014$1.23$1.32+$0.09$1.62$5.09 billion$5.06 billion
7/31/2014Q2 2014$1.22$1.23+$0.01$1.59$5.08 billion$5.00 billion  
5/1/2014Q1 2014$1.23$1.22($0.01)$1.57$5.11 million$5.00 billion  
2/6/2014Q4 2013$1.40$1.42+$0.02$2.39$5.19 billion$5.40 billion
10/31/2013Q3 2013$1.26$1.27+$0.01$1.70$5.00 billion$5.06 billion  
8/1/2013Q2 2013$1.18$1.20+$0.02$2.93$4.94 billion$4.90 billion  
5/2/2013Q1 2013$1.10$1.12+$0.02$1.50$4.85 billion$4.90 billion  
2/7/2013Q412$1.33$1.32($0.01)$5.26 billion$5.20 billion  
11/1/2012Q312$1.25$1.28+$0.03$5.08 billion$5.00 billion
11/2/2010Q3 2010$1.27$1.30+$0.03$1.45
7/26/2010Q2 2010$1.04$1.08+$0.04$1.28
5/4/2010Q1 2010$0.89$0.92+$0.03$1.05
2/16/2010Q4 2009$0.95$0.94($0.01)$1.46
11/3/2009Q3 2009$0.88$0.89+$0.01$1.06
7/28/2009Q2 2009$0.80$0.83+$0.03$1.08
5/5/2009Q1 2009$0.67$0.72+$0.05$0.93
2/17/2009Q4 2008$0.73$0.76+$0.03$2.40
11/6/2008Q3 2008$0.69$0.72+$0.03$0.67
7/29/2008Q2 2008$0.64$0.65+$0.01$0.65
5/6/2008Q1 2008$0.63$0.64+$0.01$1.10
2/12/2008Q4 2007$0.66$0.69+$0.03$0.69

Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

When is Teva Pharmaceutical Industries's earnings date?

Teva Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Wednesday, July 27th, 2022. Learn more on TEVA's earnings history.

Did Teva Pharmaceutical Industries beat their earnings estimates last quarter?

In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.53 earnings per share (EPS) to hit the analysts' consensus estimate of $0.53. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.

How can I listen to Teva Pharmaceutical Industries's earnings conference call?

The conference call for Teva Pharmaceutical Industries's latest earnings report can be listened to online. Listen to Conference Call

How can I read Teva Pharmaceutical Industries's conference call transcript?

The conference call transcript for Teva Pharmaceutical Industries's latest earnings report can be read online. Read Transcript

How much revenue does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.88 billion.

How much profit does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of $417 million. TEVA has generated -$0.55 earnings per share over the last four quarters.

What is Teva Pharmaceutical Industries's price-to-earnings ratio?

Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 3.30. The price/earnings-to-growth ratio is 0.99.

What is Teva Pharmaceutical Industries's EPS forecast for next year?

Teva Pharmaceutical Industries's earnings are expected to grow from $2.39 per share to $2.49 per share in the next year, which is a 4.18% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:TEVA) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.